Loading...
此记录已被删除。由于它已链接到已发布的记录,因此此处仅供参考。
单击此处查看已删除的记录本文档已更新。这不是最新发布的版本。 单击此处查看该记录的最新版本。
根据规定方式作出的风险评估
(RA)
last updated: 09 7月 2026
Risk assessment of the PROTEQFLU Vaccine - Technical Opinion No. 5486/2017.
EN
08 6月 2017
-
国家主管部门:National Technical Biosafety Commission ()Setor Policial Sul -SPO Área 5 Quadra 3 Bloco B - Térreo Salas 10 à 14Brasília, DF
CEP - 70610-200, 巴西电话号码: (5561) 3411-5516,传真: (5561) 3317-7475,电子邮箱地址: ctnbio@mct.gov.br,
-
组织:Merial Saúde Animal Ltda (Merial)私营部门(工商业)Fazenda São Francisco s/nº - Caixa Postal: 242 - PAULINIA (SP)Paulínia, São Paulo
13140970, 巴西电话号码: +55 19 3874-8601,传真: +55 19 3874-8080,电子邮箱地址: luciana.soares@merial.com.br,
-
Proteqflu - equine influenza vaccine| Merial | 医疗或药物化合物的生产(人或动物) (疫苗), Use as vaccine
- Commercial release 5486-2017.pdf [ 葡萄牙语 ]
ProteqFlu is a vaccine intended to protect domestic horses against equine influenza (H3N8).
There is no potential environmental hazard that can be identified by using the ProteqFlu vaccine.
Safety studies were conducted on non-target species involving canaries, ducks, chickens, pigs, rats and guinea pigs and the results support the product's safety profile.
There is no potential environmental hazard that can be identified by using the ProteqFlu vaccine.
It is not potentially causing significant environmental degradation or harmful to human health.
The analysis of the experimental data presented in the present request show that the GMOs in question are harmless to other species of animals, to man and to the environment.
The ProteqFlu vaccine is not potentially risk-causing.
The ProteqFlu vaccine, CTNBio concluded that the present request complies with the pertinent norms and legislation that aim to guarantee the biosafety of the environment, agriculture, human and animal health.
Molecular traditional methods.
是
否
否
ZH
| 记录类型 | 字段 | 记录 | |
|---|---|---|---|
| 各国的决定或其它通讯往来 | 风险评估 | 1 | |